CCM Duopharma Records 15.25% Increase in for FY2018
CCM Duopharma Biotech Berhad (CCM Duopharma) has recorded an improved Profit before Tax (PBT) of RM59.67 million for the financial year ended December 31, 2018 (FY2018), an increase of 15.25 per cent as compared to RM51.77 million in the corresponding period in 2017.